The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Efficacy of short-term psychodynamic psychotherapy (STPP) with depressed breast cancer patients: results of a randomized controlled multicenter trial
Open accessAbstract
Background There is a lack of trials of psychodynamic treatments of depression in breast cancer patients. The purpose of this trial was to determine the efficacy of short-term psychodynamic psychotherapy (STPP) in non-metastatic breast cancer patients diagnosed with depression, one of the most frequent mental comorbidities of breast cancer.Patients and methods In a multicenter prospective trial, 157 breast cancer patients with comorbid depression were randomized to either individual STPP (intervention group, N=78) or 'treatment as usual' (control group, TAU, N=79). As our primary outcome measure, we hypothesized a higher rate of remission defined as no diagnosis of depression (Structured Clinical Interview for DSM-IV) and reduction in depression score by at least 2 points (Hospital Anxiety and Depression Scale, HADS-D) in STPP versus TAU at treatment termination. Secondary outcomes mainly refer to quality of life (QoL).Results In the intention to treat (ITT) analysis, 44% of the STPP group achieved highly significantly more remission than TAU (23%). STPP treatment (OR=7.64; P<0.001) was the strongest predictor for remission post-treatment; time was also significant (OR=0.96; P<0.05). A high effect favoring STPP (d=0.82) was observed for the HADS-D score post-treatment (secondary outcome). Regarding further secondary outcomes (QoL), analyses of covariance yielded main effects for group (favoring STPP with an effect size of at least d=0.5) for global QoL, role, emotional and social functioning, pain, treatment side-effects, breast symptoms and upset by hair loss.Conclusions STPP is an effective treatment of a broad range of depressive conditions in breast cancer patients improving depression and functional QoL. Findings are limited by the drop-out rate (∼1/3) and delayed post-treatment assessments. Future trials may consider stepped-care approaches, tailored to patients' needs and requirements in the acute treatment phase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the exception of Beutel 2013, the certainty of evidence of these studies was judged as low because two or more risk of bias domains were rated as high or unclear risk of bias (Table 1).”
From Psychological interventions for women with non-metastatic breast cancer (2023) · cites this paper as Beutel 2013
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005 · cited 3×
“Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.”
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220 · cited 2×
“As main secondary outcomes, we assessed general and breast cancer-specific QoL by the EORTC Quality of Life Questionnaires C30 [8] and BR23 [9] supplemented by personality and helping alliance measures [7].”
Duijts, S. F. A., Faber, M. M., Oldenburg, H. S. A., van Beurden, M., & Aaronson, N. K. (2011) · Psycho-Oncology · doi:10.1002/pon.1728 · Cited by 452 · cited 1×
“34) on depression in breast cancer patients [2].”
Estimating remission from untreated major depression: a systematic review and meta-analysis
Whiteford, H. A., Harris, M. G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J. J., & Wang, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001717 · Cited by 375 · cited 1×
“For STPP of depression remission rates between 45% and 70% at treatment termination were published, while remission rates in primary-care settings (comparable with TAU) ranged between 20% and ∼50% [10].”
Evidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236 · cited 2×
“Depressive disorders are the most frequent mental comorbidities in ∼22% of cancer patients leading to substantial decrements of quality of life (QoL), compliance, work ability and prognosis [1].”
Duijts, S. F. A., van Beurden, M., Oldenburg, H. S. A., Hunter, M. S., Kieffer, J. M., Stuiver, M. M., Gerritsma, M. A., Menke-Pluymers, M. B. E., Plaisier, P. W., Rijna, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.8525 · Cited by 220
Factors in Outcomes of Short-Term Dynamic Psychotherapy for Chronic vs. Nonchronic Major Depression.
(1996) · PubMed Central · Cited by 29
Zwerenz, R., Beutel, M. E., Imruck, B. H., Wiltink, J., Haselbacher, A., Ruckes, C., Schmidberger, H., Hoffmann, G., Schmidt, M., Köhler, U., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-578 · Cited by 25 · cited 2×
“As specified in the study protocol [7], ANCOVA’s were carried out with fixed effects for treatment and center and baseline scores (HADS-D, EORTC QLQ) as covariates.”
Self-citationHaselbacher, A., Barthel, Y., Brähler, E., Imruck, B., Kuhnt, S., Zwerenz, R., & Beutel, M. E. (2010) · Psychotherapeut · doi:10.1007/s00278-010-0758-3 · Cited by 8 · cited 2×
“As supportive-expressive individual psychotherapy has been increasingly supported as an effective treatment of mental disorders such as depression [3], a short-term psychodynamic psychotherapy (STPP) manual was developed for depressed breast cancer patients [4].”
Self-citation
Cited by
The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis update
Driessen, E., Hegelmaier, L. M., Abbass, A. A., Barber, J. P., Dekker, J. J. M., Van, H. L., Jansma, E. P., & Cuijpers, P. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.07.004 · Cited by 409
“Yet in this last meta-analysis depression was used as the sole outcome measure and some of the more recent large studies (e.g., Beutel et al., 2014; Driessen et al., 2013) were not included (Barber et al., 2013).”
BackgroundResultShort-term psychodynamic psychotherapies for common mental disorders
Abbass, A. A., Kisely, S. R., Town, J. M., Leichsenring, F., Driessen, E., De Maat, S., Gerber, A., Dekker, J., Rabung, S., Rusalovska, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004687.pub4 · Cited by 329
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
“Twelve studies of psychological or social therapies with or without educational components were identified, with half screening patients for enrollment.(68,69,74,98,105,106) In studies using screening, all patients were described as being in the postoncologic treatment phase.”
The effectiveness of psychodynamic psychotherapies: An update
Fonagy, P. (2015) · World Psychiatry · doi:10.1002/wps.20235 · Cited by 249
Psychodynamic therapy meets evidence-based medicine: a systematic review using updated criteria
Leichsenring, F., Luyten, P., Hilsenroth, M. J., Abbass, A., Barber, J. P., Keefe, J. R., Leweke, F., Rabung, S., & Steinert, C. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00155-8 · Cited by 161
Metadata
- Authors
- Beutel, M. E., Weißflog, G., Leuteritz, K., Wiltink, J., Haselbacher, A., Ruckes, C., Kuhnt, S., Barthel, Y., Imruck, B. H., Zwerenz, R., & Brähler, E.
- Affiliations
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Leipzig University (DE)
- Corresponding author
- Weißflog, G.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 25
- Issue
- 2
- Pages
- 378-384
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2106343125
- Cited by
- 70
- References
- 10
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 2 · 2019: 6 · 2018: 3 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 6
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2110 d)
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- German Cancer Aid (107457, 109379, 107870, 109381)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- short-term dynamic psychotherapy, depression, breast cancer, cancer-related depression, psychiatric comorbidity, depression remission, quality of life, psycho-oncology, usual care
- MeSH terms
- Adolescent, Adult, Aged, Breast Neoplasms, Depression, Female, Humans, Middle Aged, Prospective Studies, Quality of Life, Treatment Outcome, Young Adult, Psychotherapy, Psychodynamic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of short-term psychodynamic psychotherapy (STPP) with depressed breast cancer patients: results of a randomized controlled multicenter trial. https://app.cochat.ai/papers/10.1093/annonc/mdt526
- The paper
- Beutel, M. E., Weißflog, G., Leuteritz, K., Wiltink, J., Haselbacher, A., Ruckes, C., Kuhnt, S., Barthel, Y., Imruck, B. H., Zwerenz, R., & Brähler, E. (2014). Efficacy of short-term psychodynamic psychotherapy (STPP) with depressed breast cancer patients: results of a randomized controlled multicenter trial. Annals of Oncology. https://doi.org/10.1093/annonc/mdt526
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.